Dramatic tumour response to pemetrexed single-agent in an elderly patient with malignant peritoneal mesothelioma: a case report
<p>Abstract</p> <p>Background</p> <p>To date, there is no standard treatment for unresectable malignant peritoneal mesothelioma; either best supportive care or systemic chemotherapy with palliative intent are accepted options.</p> <p>Case presentation</p&...
Main Authors: | Di Terlizzi Silvia, Aita Marianna, Follador Alessandro, Puglisi Fabio, Fasola Gianpiero, Belvedere Ornella |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-12-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/6/289 |
Similar Items
-
Adjuvant Bidirectional Chemotherapy with Intraperitoneal Pemetrexed Combined with Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma
by: Lana Bijelic, et al.
Published: (2012-01-01) -
Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesothelioma
by: Ranjit K Goudar
Published: (2008-03-01) -
Malignant Peritoneal Mesothelioma
by: Zhong-Yi Lin, et al.
Published: (2015-03-01) -
Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience
by: Bearz Alessandra, et al.
Published: (2012-09-01) -
Upregulation of Thymidylate Synthase Induces Pemetrexed Resistance in Malignant Pleural Mesothelioma
by: Yuzo Sato, et al.
Published: (2021-09-01)